*Doheny Image Reading Center, Doheny Eye Institute, Los Angeles, California;
†Retina Division, Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California;
‡Department of Medicine and Science of Ageing, Ophthalmology Clinic, University G. D'Annunzio Chieti-Pescara, Chieti, Italy;
§Stein Eye Institute, University of California Los Angeles, Los Angeles, California;
and **Greater Los Angeles VA Healthcare Center, Los Angeles, California.
Reprint requests: Irena Tsui, MD, Retina Division, Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; e-mail: [email protected]
This work was completed at the Department of Ophthalmology at UCLA supported by an Unrestricted Grant from Research to Prevent Blindness, Inc, to the Department of Ophthalmology at UCLA.
F. Velez receives funding support from Retrophin, Baush&Lomb, Omeros, and Research to Prevent Blindness. D. Sarraf receives funding support from Allergan, Genentech, Heidelberg, Regeneron, and Optovue and he is a consultant for Amgen, Bayer, Genentech, Heidelberg, Regeneron, Nuvelution, Novartis, and Optovue. S.R. Sadda receives funding support from Allergan, Carl Zeiss Meditec, Genentech, Optos, Optovue, and Regeneron and he is a consultant for Allergan, Genentech, Iconic, Novartis, Optos, Optovue, Regeneron, Thrombogenics, CenterVue, and Heidelberg. The remaining authors have no conflicts of interest to disclose.
